Review

mda-mb-231 (ATCC)

ATCC is a verified supplier

ATCC manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

ATCC mda-mb-231
Mda Mb 231, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 24506 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/breast+cancer+cell+lines+mda+mb+231/MDA-MB-231/custom%40htb-26%4041637552
Average 99 stars, based on 24506 article reviews

mda-mb-231 - by Bioz Stars, 2026-09

99/100 stars

Images

Multiple Displacement Amplification:

Article Title: Comprehensive mass spectrometry screening-derived atlas of HDAC inhibitors reveals histone-specific acetylation changes.
Article Snippet: .. Breast cancer cell lines MDA-MB-231 (ATCC HTB-26) and MCF-7 (ATCC, HTB-22) were cultured previously supplemented with 10% fetal bovine serum, penicillin (100 U/mL), streptomycin (100 mg/mL), and 2 mM GlutaMAX Supplement (Gibco, Cat#35050-061). .. T47D was cultured in RPMI media 1640 with 10% fetal bovine serum, penicillin (100 U/mL), streptomycin (100 mg/mL), and 1X MEM non-essential amino acid (Corning, Cat#25-025-CI).

Article Title: Exosomal miR-4443 confers cisplatin resistance in breast cancer by inhibiting ferroptosis.
Article Snippet: .. Cell culture, transfection and treatments The human breast epithelial cell line MCF-10A and breast cancer cell lines MDA-MB-231, BT-549, MDA-MB-468, and MCF-7 were obtained from the ACCEPTED MANUSCRIPT AR TIC LE IN PR ES S ARTICLE IN PRESS American Type Culture Collection (ATCC, USA). .. Cells were cultured in DMEM (Gibco, USA) supplemented with 10% fetal bovine serum (FBS; Gibco, USA) and 1% penicillin–streptomycin (Thermo Fisher Scientific, USA) at 37°C in a humidified atmosphere with 5% CO2.

Article Title: Recombinant herpes simplex virus for multiple targeting and use thereof
Article Snippet: .. For breast cancer cell lines MDA-MB-231 (ATCC, HTB-26), MCF-7 (ATCC, HTB-22), and BT-474 (ATCC, HTB-20), and an ovarian cancer cell line SK-OV-3 (ATCC, HTB-77), culture was performed using DMEM containing 100 U/ml penicillin/100 μg/ml streptomycin (Welgene) and 10% FBS, and for a breast cancer cell line MDA-MB-453 (ATCC, HTB-131), culture was performed using an RPMI 1640 medium containing 100 U/ml penicillin/100 μg/ml streptomycin (Welgene) and 10% FBS. ..

Article Title: AKAP2 is required for assembly of cytoskeletal signaling complexes that promote growth and metastasis of triple-negative breast cancer.
Article Snippet: .. Breast cancer cell lines MDA-MB-231 (ATCC catalog No. HTB-26), BT474 (ATCC catalog No. HTB-20), and HS578T (ATCC catalog No. HTB-126) were purchased from Jo urn al Pr e-p roo f ATCC (Manassas, VA). .. MDA-MB-231 cells were tested for contamination through PCR (IDEXX IMPACT I; h-IMPACT).

Article Title: AKAP2 is required for assembly of cytoskeletal signaling complexes that promote growth and metastasis of triple-negative breast cancer
Article Snippet: .. Breast cancer cell lines MDA-MB-231 (ATCC catalog No. HTB-26), BT474 (ATCC catalog No. HTB-20), and HS578T (ATCC catalog No. HTB-126) were purchased from ATCC (Manassas, VA). .. MDA-MB-231 cells were tested for contamination through PCR (IDEXX IMPACT I; h-IMPACT).

Article Title: Ribbon-shaped microgels as bioinks for 3D bioprinting of anisotropic tissue structures
Article Snippet: Human umbilical vein endothelial cells (HUVECs, Lonza) were cultured in Endothelial Cell Growth Media (R&D Systems). .. Breast cancer cell lines MDA-MB-231 (ATCC) and MCF-7 (ATCC) were lentivirus transduced to express GFP and cultured in DMEM media (4.5 g L −1 glucose) supplemented with 10 % (v/v) fetal bovine serum and 1 % (v/v) penicillin-streptomycin. ..

Article Title: GCNT3 and ST3GAL1 expression correlates with HER2 status and MUC1/β-catenin/Cyclin D1 axis in breast cancer
Article Snippet: Mycoplasma free cell lines were procured from American Type Culture Collection (ATCC, USA) and were subcultured on reaching appropriate confluence. .. Breast cancer cell lines MDA-MB-231 (ATCC Catalog HTB-26), MDA-MB-435 (ATCC Catalog HTB-129), and MCF-7 (ATCC Catalog HTB-22) were cultured along with a control cell line HEK-293 (ATCC Catalog CRL-1573) in Dulbecco’s Modified Eagle Medium (DMEM). .. HER2 positive cell line SKBR3 (ATCC Catalog HTB-30) was cultured in McCoy’s 5 A medium.

Article Title: GCNT3 and ST3GAL1 expression correlates with HER2 status and MUC1/β-catenin/Cyclin D1 axis in breast cancer.
Article Snippet: AR TIC LE IN PR ES S Cell culture: Mycoplasma free cell lines were procured from American Type Culture Collection (ATCC, USA) and were subcultured on reaching appropriate confluence. .. Breast cancer cell lines MDA-MB-231 (ATCC Catalog HTB-26), MDA-MB-435 (ATCC Catalog HTB-129), and MCF-7 (ATCC Catalog HTB-22) were cultured along with a control cell line HEK-293 (ATCC Catalog CRL-1573) in Dulbecco's Modified Eagle Medium (DMEM). .. HER2 positive cell line SKBR3 (ATCC Catalog HTB-30) was cultured in McCoy’s 5A medium.

Cell Culture:

Transfection:

Control:

Modification:

Image Search Results

Ptch1 is expressed in breast cancer cell lines. A. PTCH1 mRNA expression (log 2 transformed) in various luminal and HER2 breast cancer cell lines (dark green) and in TNBC cell lines (other colors). TNBC cell lines are depicted according to the “Lehmann TNBC subtype” nomenclature : basal-like 1 (yellow), basal-like 2 (pale green), immunomodulatory (brown), luminal androgen receptor (dark pink), mesenchymal (pale pink) and mesenchymal stem-like (pink). B. PTCH1 protein expression in three TNBC cell lines. Western-blot was performed on 50 µg extracts from TNBC cell lines (MDA-MB-231, HCC-38 and MDA-MB-468) with antibodies directed against PTCH1. PTCH1 and GAPDH signals were quantified using ImageJ software. Data presented are the mean ± SEM of at least 3 independent experiments. Significance is calculated using Oneway ANOVA Turkey’s multiple comparisons test and attained at P < 0.05 (*).

Journal: Translational Oncology

Article Title: Inhibition of PTCH1 drug efflux activity enhances chemotherapy efficacy against triple negative breast cancers

doi: 10.1016/j.tranon.2026.102777

Figure Lengend Snippet: Ptch1 is expressed in breast cancer cell lines. A. PTCH1 mRNA expression (log 2 transformed) in various luminal and HER2 breast cancer cell lines (dark green) and in TNBC cell lines (other colors). TNBC cell lines are depicted according to the “Lehmann TNBC subtype” nomenclature : basal-like 1 (yellow), basal-like 2 (pale green), immunomodulatory (brown), luminal androgen receptor (dark pink), mesenchymal (pale pink) and mesenchymal stem-like (pink). B. PTCH1 protein expression in three TNBC cell lines. Western-blot was performed on 50 µg extracts from TNBC cell lines (MDA-MB-231, HCC-38 and MDA-MB-468) with antibodies directed against PTCH1. PTCH1 and GAPDH signals were quantified using ImageJ software. Data presented are the mean ± SEM of at least 3 independent experiments. Significance is calculated using Oneway ANOVA Turkey’s multiple comparisons test and attained at P < 0.05 (*).

Article Snippet: Human breast cancer cell lines MDA-MB-231, MDA-MB-468 and HCC-38 were purchased from ATCC.

Techniques: Expressing, Transformation Assay, Western Blot, Software

PTCH1 drug efflux inhibitor PAH increases the sensitivity of TNBC cells to chemotherapy . Cell viability was measured after 24 h or 48 h treatment with increasing concentration of docetaxel or doxorubicin respectively on MDA-MB-231, MDA-MB-468 and HCC-38 cell lines in the absence or the presence of 15µM PAH. IC 50 values (corresponding to the concentration of chemotherapy inducing 50% of cell death) were calculated. Data reported are the mean ± SEM of at least 3 independent experiments. Significance is attained at P < 0.05 (*).

Journal: Translational Oncology

Article Title: Inhibition of PTCH1 drug efflux activity enhances chemotherapy efficacy against triple negative breast cancers

doi: 10.1016/j.tranon.2026.102777

Figure Lengend Snippet: PTCH1 drug efflux inhibitor PAH increases the sensitivity of TNBC cells to chemotherapy . Cell viability was measured after 24 h or 48 h treatment with increasing concentration of docetaxel or doxorubicin respectively on MDA-MB-231, MDA-MB-468 and HCC-38 cell lines in the absence or the presence of 15µM PAH. IC 50 values (corresponding to the concentration of chemotherapy inducing 50% of cell death) were calculated. Data reported are the mean ± SEM of at least 3 independent experiments. Significance is attained at P < 0.05 (*).

Article Snippet: Human breast cancer cell lines MDA-MB-231, MDA-MB-468 and HCC-38 were purchased from ATCC.

Techniques: Concentration Assay

Other multidrug transporters are expressed in TNBC cell lines. A. P-gp and ABCG2 protein expression in three TNBC cell lines. Western-blot was performed on 50 µg extracts from each TNBC cell line (MDA-MB-231, HCC-38 and MDA-MB-468) with antibodies directed against P-gp or ABCG2 and GAPDH. B. P-gp, ABCG2 and GAPDH signals were quantified using ImageJ software. Data presented are the mean ± SEM of at least 3 independent experiments. Significance is calculated using Oneway ANOVA Turkey’s multiple comparisons test and attained at P < 0.05 (*). ** P < 0.01; *** P < 0.001; ns P > 0.05.

Journal: Translational Oncology

Article Title: Inhibition of PTCH1 drug efflux activity enhances chemotherapy efficacy against triple negative breast cancers

doi: 10.1016/j.tranon.2026.102777

Figure Lengend Snippet: Other multidrug transporters are expressed in TNBC cell lines. A. P-gp and ABCG2 protein expression in three TNBC cell lines. Western-blot was performed on 50 µg extracts from each TNBC cell line (MDA-MB-231, HCC-38 and MDA-MB-468) with antibodies directed against P-gp or ABCG2 and GAPDH. B. P-gp, ABCG2 and GAPDH signals were quantified using ImageJ software. Data presented are the mean ± SEM of at least 3 independent experiments. Significance is calculated using Oneway ANOVA Turkey’s multiple comparisons test and attained at P < 0.05 (*). ** P < 0.01; *** P < 0.001; ns P > 0.05.

Article Snippet: Human breast cancer cell lines MDA-MB-231, MDA-MB-468 and HCC-38 were purchased from ATCC.

Techniques: Expressing, Western Blot, Software

PAH increases docetaxel efficacy against TNBC spheroids. MDA-MB-231 cells were plated in ultra-low attachment surface 24 well plates in complete medium and treated with increasing concentrations of docetaxel in the presence of DMSO (control, 0 PAH), PAH 10 µM or 30 µM. After 2 weeks pictures were taken using Cytation 5 cell imaging system from Biotek. The surface of spheroids was calculated and reported after normalization on the condition without docetaxel for each concentration of PAH.

Journal: Translational Oncology

Article Title: Inhibition of PTCH1 drug efflux activity enhances chemotherapy efficacy against triple negative breast cancers

doi: 10.1016/j.tranon.2026.102777

Figure Lengend Snippet: PAH increases docetaxel efficacy against TNBC spheroids. MDA-MB-231 cells were plated in ultra-low attachment surface 24 well plates in complete medium and treated with increasing concentrations of docetaxel in the presence of DMSO (control, 0 PAH), PAH 10 µM or 30 µM. After 2 weeks pictures were taken using Cytation 5 cell imaging system from Biotek. The surface of spheroids was calculated and reported after normalization on the condition without docetaxel for each concentration of PAH.

Article Snippet: Human breast cancer cell lines MDA-MB-231, MDA-MB-468 and HCC-38 were purchased from ATCC.

Techniques: Control, Imaging, Concentration Assay

PAH addition to chemotherapy inhibits migration of TNBC cells. A. 100000 cells were seeded on membrane from Transwell plates. Cells were treated 24 h with doxorubicin ± 15µM PAH or 48 h with docetaxel ± 15µM PAH. After fixation and staining with crystal violet, wells were observed on a microscope with X5 objective. B. Migration was measured using a wound-healing assay. A wound was performed on MDA-MB-231 confluent cells seeded in 24 well plates. The medium was replaced by fresh medium containing 5 µM docetaxel in the absence of PAH, or the presence of 5 µM PAH. Two pictures were taken at two different points of each well immediately after wound, and 3 days after wound with 5X objective. The width of the wound was measured using ImageJ software and reported as final wound width/initial wound width in percentage. Data presented are the mean ± SEM of 3 independent experiments. Significance is attained at P < 0.05.

Journal: Translational Oncology

Article Title: Inhibition of PTCH1 drug efflux activity enhances chemotherapy efficacy against triple negative breast cancers

doi: 10.1016/j.tranon.2026.102777

Figure Lengend Snippet: PAH addition to chemotherapy inhibits migration of TNBC cells. A. 100000 cells were seeded on membrane from Transwell plates. Cells were treated 24 h with doxorubicin ± 15µM PAH or 48 h with docetaxel ± 15µM PAH. After fixation and staining with crystal violet, wells were observed on a microscope with X5 objective. B. Migration was measured using a wound-healing assay. A wound was performed on MDA-MB-231 confluent cells seeded in 24 well plates. The medium was replaced by fresh medium containing 5 µM docetaxel in the absence of PAH, or the presence of 5 µM PAH. Two pictures were taken at two different points of each well immediately after wound, and 3 days after wound with 5X objective. The width of the wound was measured using ImageJ software and reported as final wound width/initial wound width in percentage. Data presented are the mean ± SEM of 3 independent experiments. Significance is attained at P < 0.05.

Article Snippet: Human breast cancer cell lines MDA-MB-231, MDA-MB-468 and HCC-38 were purchased from ATCC.

Techniques: Migration, Membrane, Staining, Microscopy, Wound Healing Assay, Software

PTCH1 contributes to the efflux of doxorubicin from TNBC cells. A. PTCH1 protein expression (left panel) and intracellular doxorubicin (right panel) were analyzed 16 h after transfection of MDA-MB-231 cells with PTCH1-siRNA or negative-control-siRNA. PTCH1 and GAPDH western blot signals were quantified using ImageJ software (left panel). For doxorubicin accumulation measurements (right panel), MDA-MB-231 cells were grown on slides and transfected with PTCH1-siRNA or negative-control-siRNA. After incubation with 10 µM doxorubicin, 3 coverslips were fixed for doxorubicin loading control; the other coverslips were incubated with efflux buffer and fixed. B. Docetaxel inhibits the accumulation of doxorubicin in MDA-MB-231 cells. Cells on coverslip were incubated with 10 µM doxorubicin or 10 µM doxorubicin and 50 µM docetaxel. Doxorubicin fluorescence images were acquired by epifluorescence microscopy using a 40X objective, and doxorubicin fluorescence was quantified using ImageJ software for about 100 cells per condition per experiment. Histograms are the mean ± SEM of 3 independent experiments. Significance is attained at P < 0.05.

Journal: Translational Oncology

Article Title: Inhibition of PTCH1 drug efflux activity enhances chemotherapy efficacy against triple negative breast cancers

doi: 10.1016/j.tranon.2026.102777

Figure Lengend Snippet: PTCH1 contributes to the efflux of doxorubicin from TNBC cells. A. PTCH1 protein expression (left panel) and intracellular doxorubicin (right panel) were analyzed 16 h after transfection of MDA-MB-231 cells with PTCH1-siRNA or negative-control-siRNA. PTCH1 and GAPDH western blot signals were quantified using ImageJ software (left panel). For doxorubicin accumulation measurements (right panel), MDA-MB-231 cells were grown on slides and transfected with PTCH1-siRNA or negative-control-siRNA. After incubation with 10 µM doxorubicin, 3 coverslips were fixed for doxorubicin loading control; the other coverslips were incubated with efflux buffer and fixed. B. Docetaxel inhibits the accumulation of doxorubicin in MDA-MB-231 cells. Cells on coverslip were incubated with 10 µM doxorubicin or 10 µM doxorubicin and 50 µM docetaxel. Doxorubicin fluorescence images were acquired by epifluorescence microscopy using a 40X objective, and doxorubicin fluorescence was quantified using ImageJ software for about 100 cells per condition per experiment. Histograms are the mean ± SEM of 3 independent experiments. Significance is attained at P < 0.05.

Article Snippet: Human breast cancer cell lines MDA-MB-231, MDA-MB-468 and HCC-38 were purchased from ATCC.

Techniques: Expressing, Transfection, Negative Control, Western Blot, Software, Incubation, Control, Fluorescence, Epifluorescence Microscopy

( a ) ARHGEF7 (human isoform-a, 646 residues, NM_001113513) domains, structure, and selected residues. The structure is an AlphaFold model (AF-Q14155-1-F1-model_v6_isoform_a) of ARHGEF7 showing the structured SH3, DH, and PH domains with cysteines and nearby residues. ( b ) Accessible surface areas (ASA) of cysteines in ARHGEF7. ( c ) Sequence alignments around C312 in ARHGEF7 orthologs. ( d ) Clickable glutathione approach. Cells expressing a glutathione synthetase mutant (GS M4) synthesize and produce clickable glutathione (N 3 -GSH) using endogenous γGlu-Cys and exogenous azido-Ala. Clickable glutathione forms S-glutathionylation with proteins, which are analyzed after click reactions. ( e - f ) Glutathionylation of ARHGEF7 WT and cysteine mutants in MDA-MB-231 cells in response to high glucose (HG, 25 mM) or low glucose (LG, 5 mM) conditions: cells were incubated for 20 h (n=3). ( g - h ) Glutathionylation of ARHGEF7 constructs in MDA-MB-231 cells upon adding EGF (n=3). EGF was incubated for 20 h. The lysates were used for click reactions with biotin-alkyne and analyzed by western blot with FLAG antibody before (input) and after (eluted) pull-down with streptavidin-agarose. Data represent the mean ± SD. The statistical difference was analyzed by one-way ANOVA and Tukey’s post-hoc test ( e - h ), where *p < 0.03, **p < 0.002, ***p < 0.0002, ****p < 0.0001.

Journal: bioRxiv

Article Title: ARHGEF7 S-glutathionylation promotes cancer cell migration through Rac1 activation

doi: 10.64898/2026.05.01.722049

Figure Lengend Snippet: ( a ) ARHGEF7 (human isoform-a, 646 residues, NM_001113513) domains, structure, and selected residues. The structure is an AlphaFold model (AF-Q14155-1-F1-model_v6_isoform_a) of ARHGEF7 showing the structured SH3, DH, and PH domains with cysteines and nearby residues. ( b ) Accessible surface areas (ASA) of cysteines in ARHGEF7. ( c ) Sequence alignments around C312 in ARHGEF7 orthologs. ( d ) Clickable glutathione approach. Cells expressing a glutathione synthetase mutant (GS M4) synthesize and produce clickable glutathione (N 3 -GSH) using endogenous γGlu-Cys and exogenous azido-Ala. Clickable glutathione forms S-glutathionylation with proteins, which are analyzed after click reactions. ( e - f ) Glutathionylation of ARHGEF7 WT and cysteine mutants in MDA-MB-231 cells in response to high glucose (HG, 25 mM) or low glucose (LG, 5 mM) conditions: cells were incubated for 20 h (n=3). ( g - h ) Glutathionylation of ARHGEF7 constructs in MDA-MB-231 cells upon adding EGF (n=3). EGF was incubated for 20 h. The lysates were used for click reactions with biotin-alkyne and analyzed by western blot with FLAG antibody before (input) and after (eluted) pull-down with streptavidin-agarose. Data represent the mean ± SD. The statistical difference was analyzed by one-way ANOVA and Tukey’s post-hoc test ( e - h ), where *p < 0.03, **p < 0.002, ***p < 0.0002, ****p < 0.0001.

Article Snippet: Breast cancer cell line MDA-MB-231 (ATCC, HTB-26TM) and breast cancer cell line MDA-MB-468 (ATCC, HTB-132TM) were maintained in Dulbecco’s Modified Eagle Medium with high glucose (DMEM, Cytiva, HycloneTM) supplemented with 10% Fetal Bovine Serum (FBS, Cytiva, HycloneTM) and 1% (100 U/mL) Penicillin-Streptomycin (Pen-strep, Thermo Scientific) in a humified incubator at 37°C in a 5% CO 2 environment.

Techniques: Sequencing, Expressing, Mutagenesis, Incubation, Construct, Western Blot

( a - b ) In-vitro scratch migration analysis of MDA-MB-231 cells expressing ARHGEF7 construct in high glucose (HG, 25 mM) or low glucose (LG, 5 mM) conditions (n=4) ( a ) or in response to EGF (n=9) ( b ). Yellow indicates areas without cells. ( c - d ) Transwell invasion analysis of MDA-MB-231 cells expressing ARHGEF7 constructs in HL or LG (n=3) ( c ) or upon incubating EGF (n=3) ( d ). Cells were incubated in HG or LG ( a , c ) or with EGF for 20 h ( b , d ). A scale bar = 500 μm. Data represent the mean ± SD. The statistical difference was analyzed by two-way ANOVA and Tukey’s post-hoc test ( a - d ), where *p < 0.03, **p < 0.002, ***p < 0.0002, ****p < 0.0001.

Journal: bioRxiv

Article Title: ARHGEF7 S-glutathionylation promotes cancer cell migration through Rac1 activation

doi: 10.64898/2026.05.01.722049

Figure Lengend Snippet: ( a - b ) In-vitro scratch migration analysis of MDA-MB-231 cells expressing ARHGEF7 construct in high glucose (HG, 25 mM) or low glucose (LG, 5 mM) conditions (n=4) ( a ) or in response to EGF (n=9) ( b ). Yellow indicates areas without cells. ( c - d ) Transwell invasion analysis of MDA-MB-231 cells expressing ARHGEF7 constructs in HL or LG (n=3) ( c ) or upon incubating EGF (n=3) ( d ). Cells were incubated in HG or LG ( a , c ) or with EGF for 20 h ( b , d ). A scale bar = 500 μm. Data represent the mean ± SD. The statistical difference was analyzed by two-way ANOVA and Tukey’s post-hoc test ( a - d ), where *p < 0.03, **p < 0.002, ***p < 0.0002, ****p < 0.0001.

Techniques: In Vitro, Migration, Expressing, Construct, Incubation

Analysis of ARHGEF7 protein interactions and Rac1-PAK1 downstream signaling. MDA-MB-231 cells expressing ARHGEF7 WT or C312S were incubated in high glucose (HG, 25 mM) or low glucose (LG, 5 mM) for 20 h. ( a ) ARHGEF7 S-glutathionylation increases its binding to Rac1. ARHGEF7 co-immunoprecipitation (co-IP) with Rac1 and PAK1 (n=3). ( b ) Rac1 is activated upon ARHGEF7 S-glutathionylation. Active Rac1 was enriched by purified GST-PBD (p21-binding domain derived from PAK1) and analyzed by western blots (n=3). ( c ) ARHGEF7 S-glutathionylation activates PAK1 and its downstream signaling. Phosphorylation levels of PAK1, LIMK1, and MEK1/2 were analyzed by western blot (n=3). ( d ) ARHGEF7 S-glutathionylation increases Rac1 localization at the cell periphery. The co-localization images of ARHGEF7 and Rac1 (left). Cells were fixed and analyzed by antibodies to FLAG (green) and Rac1/Cdc42 (red) (n=10 images). White arrows indicate the intense co-localization of ARHGEF7 and Rac1. Pearson’s correlation coefficients (right) were calculated after Intermodes thresholding to select for colocalization of ARHGEF7 and Rac1 at the cell periphery (see also Figure S6). A scale bar = 10 μm. Data represent the mean ± SD. The statistical difference was analyzed by one-way ANOVA and Tukey’s post-hoc test ( a-d ), where *p < 0.03, **p < 0.002, ***p < 0.0002, ****p < 0.0001.

Journal: bioRxiv

Article Title: ARHGEF7 S-glutathionylation promotes cancer cell migration through Rac1 activation

doi: 10.64898/2026.05.01.722049

Figure Lengend Snippet: Analysis of ARHGEF7 protein interactions and Rac1-PAK1 downstream signaling. MDA-MB-231 cells expressing ARHGEF7 WT or C312S were incubated in high glucose (HG, 25 mM) or low glucose (LG, 5 mM) for 20 h. ( a ) ARHGEF7 S-glutathionylation increases its binding to Rac1. ARHGEF7 co-immunoprecipitation (co-IP) with Rac1 and PAK1 (n=3). ( b ) Rac1 is activated upon ARHGEF7 S-glutathionylation. Active Rac1 was enriched by purified GST-PBD (p21-binding domain derived from PAK1) and analyzed by western blots (n=3). ( c ) ARHGEF7 S-glutathionylation activates PAK1 and its downstream signaling. Phosphorylation levels of PAK1, LIMK1, and MEK1/2 were analyzed by western blot (n=3). ( d ) ARHGEF7 S-glutathionylation increases Rac1 localization at the cell periphery. The co-localization images of ARHGEF7 and Rac1 (left). Cells were fixed and analyzed by antibodies to FLAG (green) and Rac1/Cdc42 (red) (n=10 images). White arrows indicate the intense co-localization of ARHGEF7 and Rac1. Pearson’s correlation coefficients (right) were calculated after Intermodes thresholding to select for colocalization of ARHGEF7 and Rac1 at the cell periphery (see also Figure S6). A scale bar = 10 μm. Data represent the mean ± SD. The statistical difference was analyzed by one-way ANOVA and Tukey’s post-hoc test ( a-d ), where *p < 0.03, **p < 0.002, ***p < 0.0002, ****p < 0.0001.

Techniques: Expressing, Incubation, Binding Assay, Immunoprecipitation, Co-Immunoprecipitation Assay, Purification, Derivative Assay, Western Blot, Phospho-proteomics

Cell viability of the cell lines MCF-10A (A), MCF-7 (B), and MDA-MB-231 (C) after treatments with IsCT1 (green bars) or AKFK-IsCT1 (purple bars) at concentrations up to 4.0 μM, followed by incubation at 37 °C and 5% CO 2 for 4 h. Green bars represent IsCT1, and pink bars represent AKFK-IsCT1. Data are expressed as mean ± SD of three independent experiments performed in triplicate. Statistical significance was determined using two-way ANOVA followed by Tukey test, ** p < 0.005; **** p < 0.0001.

Journal: ACS Pharmacology & Translational Science

Article Title: Engineering the Host Defense Peptide from Scorpion Venom for Safer and More Potent Antibreast Cancer Activity

doi: 10.1021/acsptsci.5c00598

Figure Lengend Snippet: Cell viability of the cell lines MCF-10A (A), MCF-7 (B), and MDA-MB-231 (C) after treatments with IsCT1 (green bars) or AKFK-IsCT1 (purple bars) at concentrations up to 4.0 μM, followed by incubation at 37 °C and 5% CO 2 for 4 h. Green bars represent IsCT1, and pink bars represent AKFK-IsCT1. Data are expressed as mean ± SD of three independent experiments performed in triplicate. Statistical significance was determined using two-way ANOVA followed by Tukey test, ** p < 0.005; **** p < 0.0001.

Article Snippet: The triple-negative breast cancer (TNBC) cell lines human MDA-MB-231 (CRM-HTB-26) and murine 4T1 (CRL-2539), human adenocarcinoma cell line MCF-7 (HTB-22), and the human breast epithelial cell line MCF-10A (CRL-10317) were obtained from American Type Culture Collection (ATCC).

Techniques: Incubation

Cell viability after combined treatment with photodynamic therapy using hypericin (PDT-Hyp, 0.05 μM) and peptides under two treatment protocols. Protocol 1 (PDT-Hyp followed by peptide exposure) was applied to (A) MCF-10A, (B) MCF-7, and (C) MDA-MB-231 cells, whereas Protocol 2 (peptide exposure followed by PDT-Hyp) was applied to (D) MCF-10A, (E) MCF-7, and (F) MDA-MB-231 cells. Blue bars represent IsCT1, and red bars represent AKFK-IsCT1. Peptides were tested at concentrations ranging from 0.01 to 4.0 μM. Cells were incubated at 37 °C and 5% CO 2 for 4 h following treatment. Data are expressed as mean ± SD of three independent experiments performed in triplicate. Statistical significance was determined using two-way ANOVA followed by Tukey test, * p < 0.05; ** p < 0.005; *** p < 0.0005; **** p < 0.0001.

Journal: ACS Pharmacology & Translational Science

Article Title: Engineering the Host Defense Peptide from Scorpion Venom for Safer and More Potent Antibreast Cancer Activity

doi: 10.1021/acsptsci.5c00598

Figure Lengend Snippet: Cell viability after combined treatment with photodynamic therapy using hypericin (PDT-Hyp, 0.05 μM) and peptides under two treatment protocols. Protocol 1 (PDT-Hyp followed by peptide exposure) was applied to (A) MCF-10A, (B) MCF-7, and (C) MDA-MB-231 cells, whereas Protocol 2 (peptide exposure followed by PDT-Hyp) was applied to (D) MCF-10A, (E) MCF-7, and (F) MDA-MB-231 cells. Blue bars represent IsCT1, and red bars represent AKFK-IsCT1. Peptides were tested at concentrations ranging from 0.01 to 4.0 μM. Cells were incubated at 37 °C and 5% CO 2 for 4 h following treatment. Data are expressed as mean ± SD of three independent experiments performed in triplicate. Statistical significance was determined using two-way ANOVA followed by Tukey test, * p < 0.05; ** p < 0.005; *** p < 0.0005; **** p < 0.0001.

Techniques: Incubation

Three-dimensional Bliss synergy response surfaces for the combined treatment of PDT-Hyp and peptides applied under different treatment protocols. Protocol 1 was evaluated with IsCT1 (A, E, I) or AKFK-IsCT1 (C, G, K), whereas Protocol 2 was evaluated with IsCT1 (B, F, J) or AKFK-IsCT1 (D, H, L). Panels in the first row (A–D) correspond to MCF-10A cells, the second row (E–H) to MCF-7 cells, and the third row (I–L) to MDA-MB-231 cells. Color coding represents Bliss synergy scores, where green indicates antagonism (≤0), intermediate colors between white and light red indicate additive effects (>0 and ≤10), and red indicates synergistic interactions (>10). Color intensity is proportional to the magnitude of the interaction score. Bliss synergy scores and response surfaces were generated from complete dose–response matrices using SynergyFinder 3.0.

Journal: ACS Pharmacology & Translational Science

Article Title: Engineering the Host Defense Peptide from Scorpion Venom for Safer and More Potent Antibreast Cancer Activity

doi: 10.1021/acsptsci.5c00598

Figure Lengend Snippet: Three-dimensional Bliss synergy response surfaces for the combined treatment of PDT-Hyp and peptides applied under different treatment protocols. Protocol 1 was evaluated with IsCT1 (A, E, I) or AKFK-IsCT1 (C, G, K), whereas Protocol 2 was evaluated with IsCT1 (B, F, J) or AKFK-IsCT1 (D, H, L). Panels in the first row (A–D) correspond to MCF-10A cells, the second row (E–H) to MCF-7 cells, and the third row (I–L) to MDA-MB-231 cells. Color coding represents Bliss synergy scores, where green indicates antagonism (≤0), intermediate colors between white and light red indicate additive effects (>0 and ≤10), and red indicates synergistic interactions (>10). Color intensity is proportional to the magnitude of the interaction score. Bliss synergy scores and response surfaces were generated from complete dose–response matrices using SynergyFinder 3.0.

Techniques: Generated

Review

mda-mb-231 (ATCC)

Structured Review

Images

Related Articles

Multiple Displacement Amplification:

Cell Culture:

Transfection:

Control:

Modification:

Similar Products

Image Search Results